A型肉毒毒素与曲安奈德单药及联合治疗人增生性瘢痕的动物模型比较
结果显示四组瘢痕重量减少、核心蛋白聚糖染色及成纤维细胞增殖抑制均有显著差异,联合治疗优于单药治疗。
要点
- 两药联合组瘢痕重量减少30%,优于A型肉毒毒素单药23%和曲安奈德单药17%。
- 联合组成纤维细胞增殖降至0.08,显著低于单药组和对照组。
- 单药及联合治疗均显示较强核心蛋白聚糖染色。
核心结论
- A型肉毒毒素与曲安奈德联合局部注射治疗人增生性瘢痕可能具有潜力。
主要发现
- 瘢痕重量减少率:对照组10%、曲安奈德组17%、A型肉毒毒素组23%、联合组30%,四组间差异显著(p < 0.05)。
- 成纤维细胞增殖减少:对照组0.58、曲安奈德组0.44、A型肉毒毒素组0.21、联合组0.08,四组间差异显著(p < 0.05)。
- 治疗组(曲安奈德、A型肉毒毒素及联合组)均显示强核心蛋白聚糖染色。
关键数值与推荐
- A型肉毒毒素或曲安奈德病灶内单药治疗较对照组显示显著疗效。
- 联合治疗较单药治疗进一步显示显著疗效。
临床怎么用
- 可考虑将A型肉毒毒素与曲安奈德联合病灶内注射用于增生性瘢痕治疗,但需结合动物模型结果谨慎外推至临床。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The authors evaluated the efficacy of a combined regimen of botulinum toxin type A (Botox) and a steroid (triamcinolone acetonide) for treating hypertrophic scars in comparison with the treatment with each drug alone. METHODS: Twenty excised human hypertrophic scar fragments obtained from surgically treated burn patients were divided into four groups: negative control (group A), triamcinolone alone (group B), Botox alone (group C), and a combination of triamcinolone and Botox (group D). These specimens were implanted into the backs of nude mice after intralesional injection from each group and were observed for 4 weeks. In total, 12 mice and 48 scars were studied. After 4 weeks, the hypertrophic scars were removed from the backs. The authors compared the scar weights, decorin staining, and the Cell Counting Kit-8 assay to evaluate treatment efficacy. RESULTS: Significant differences in scar weight reduction were observed among the four groups (group A, 10 percent; group B, 17 percent; group C, 23 percent; and group D, 30 percent; p < 0.05). Treatment groups (groups B, C, and D) showed strong decorin staining. Significant differences in reduction of fibroblast proliferation were observed among the four groups (group A, 0.58; group B, 0.44; group C, 0.21; and group D, 0.08; p < 0.05). Botox or triamcinolone intralesional monotherapy showed significant therapeutic efficacy compared with the control group. The combined therapy further exhibited a significant therapeutic effect compared with monotherapy. CONCLUSION: This study indicates the potential of Botox and triamcinolone when combined for intralesional therapy in treating hypertrophic scars.
引用
- Chen HC, Yen CI, Yang SY, et al. Comparison of Steroid and Botulinum Toxin Type A Monotherapy with Combination Therapy for Treating Human Hypertrophic Scars in an Animal Model. Plast Reconstr Surg. 2017. PMID: 28654594. doi:10.1097/PRS.0000000000003426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。